- Home
- LENZ vs DIAX Comparison
LENZ vs DIAX Comparison
Compare LENZ & DIAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$8.29
Company Overview
Basic Information| Metric | LENZ | DIAX |
|---|---|---|
| Founded | 2019 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 609.5M | 525.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | LENZ | DIAX |
|---|---|---|
| Price | $8.29 | $14.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $45.60 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 93.1K |
| Earning Date | 03-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.93% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,088,000.00 | N/A |
| Revenue This Year | $162.79 | N/A |
| Revenue Next Year | $170.32 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.40 | $12.42 |
| 52 Week High | $50.19 | $15.85 |
Technical Indicators
Market Signals| Indicator | LENZ | DIAX |
|---|---|---|
| Relative Strength Index (RSI) | 27.19 | 30.87 |
| Support Level | N/A | $13.73 |
| Resistance Level | $12.70 | $14.45 |
| Average True Range (ATR) | 0.83 | 0.21 |
| MACD | -0.23 | -0.04 |
| Stochastic Oscillator | 0.45 | 10.26 |
Price Performance
Historical Comparison LENZ
DIAX
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About DIAX Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest
Nuveen Dow 30sm Dynamic Overwrite Fund is a non-diversified closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the S&P 500 Index.